Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Office Depot Inc. ( ODP - Analyst Report ) , one of the leading suppliers of office products and services, has relocated its store in Orland Parkto 15202 S. LaGrange Road from 1 Orland Park Place Suite 190, with a new shopper-friendly layout.
The company is focusing on smaller format stores and enhancing shoppers’ experience through store renovations. This in turn, will facilitate it in improving store sales productivity.
Earlier, the company announced the redesigning of its Salisbury store in North Carolina with a new layout. Moreover, the company relocated its store in Daphne to another location.
Office Depot, through this remodeling and relocation, intends to make its stores more accessible and interactive, with emphasis on customers’ preferences. Alongside, Office Depot aims to downsize or relocate about 500 outlets into a small or mid-size format.
The company will also shut down 10 to 20 stores in 2013 due to the expiration of leases. During 2013, Office Depot plans to downsize or relocate about 100 large size outlets. Of these, majority of the outlets will be remodeled into a smaller format size of 5,000 to 7,000 square feet and the rest of the stores will range between 15,000 to 17,000 square feet.
Further, the company is contemplating to strengthen its global footprint and reviewing capital-efficient opportunities to expand its reach in Eastern Europe, Asia and South America. The company believes that India and China will provide significant growth opportunities.
As business budget remains tight, consumers and small businesses remain frugal about big-ticket spending on items such as business machines and other durable products. Thus, the companies are coming up with new and innovative strategies to navigate through the challenging environment.
Currently, we maintain our long-term Neutral recommendation on the stock. Moreover, Office Depot, which competes with OfficeMax Inc. ( OMX - Analyst Report ) and Staples Inc. ( SPLS - Analyst Report ) , holds a Zacks Rank # 2 (Buy).
Read the full Analyst Report on ODP
Read the full Analyst Report on SPLS
Read the full Analyst Report on OMX